Board certified in Neurology by American Board of Neurology & Psychiatry (ABPN), Board certified in Clinical Neurophysiology sub-specialty certification by ABPN, Board certified in Clinical Neurophysiologic Epilepsy monitoring and Intra-operative monitoring by American Board of Clinical Neurophysiology (ABCN), Board certified in Headache Medicine by United Council for Neurologic Subspecialities (UCNS),
Sutter Health Research Enterprise
1501 Trousdale Drive
Building B, Floor 4
Burlingame, CA, 94010
(650) 652-8350
Brajesh.Agrawal@sutterhealth.org
Primary Research Interests
Related Clinical Trials
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 over 52 Weeks in Participants with Early Alzheimer’s Disease
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants with Early Alzheimer’s Disease
Investigators: Brajesh Agrawal MD, Minal Bhanushali MD, PAMFRI Medical Director
Status: Active, Recruiting
New IDEAS: Imaging Dementia—Evidence for Amyloid Scanning Study
A Study to Improve Precision in Amyloid PET Coverage and Patient Care
Investigators: Brajesh Agrawal MD, Minal Bhanushali MD, PAMFRI Medical Director, David Eric Collins MD
Status: Completed